We are live on
!
Find out more
SHI
SV Health Investors Portfolio holdings
AUM
$32.3M
1-Year Est. Return
20.15%
This Fund
S&P 500
This Quarter
Est. Return
+9.97%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$197M
AUM Growth
+$53.2M
(+37%)
Cap. Flow
+$48.8M
Cap. Flow
% of AUM
24.74%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Well
AMWL
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ocular Therapeutix
OCUL
|
+$2.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SAM
FCOMV
LUGPSI
VCA
PGM
ACM
KCM
KXA
SV Health Investors's Q3 2020 Portfolio in Review
As of Q3 2020, SV Health Investors held 11 positions worth $197M, up 37% from $144M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
SV Health Investors deployed $48.8M of net new capital in Q3 2020, opening 1 new position. Its largest new stake was American Well: 97,467 shares worth $57.8M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
On the sell side, the most notable exit was Ocular Therapeutix, an estimated $2.6M sold.
- SV Health Investors's largest Q3 2020 buy was American Well: 97,467 shares worth $57.8M.
- SV Health Investors fully exited Ocular Therapeutix in Q3 2020, selling an estimated $2.6M.
- SV Health Investors's ten largest holdings make up 100% of its $197M portfolio in Q3 2020.
- SV Health Investors opened 1 new position and closed 1 in Q3 2020.
- SV Health Investors's portfolio value rose 37% quarter-over-quarter to $197M.
Based on SV Health Investors's 13F filing for Q3 2020, filed 12 Nov 2020.